RBC Capital initiated coverage of Sophia Genetics with an Outperform rating and $8 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SOPH:
- Sophia Genetics expands relationship with largest health center in Italy
- SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023
- Sophia Genetics sees 2023 revenue growth at or above 30%, consensus $62.08M
- Sophia Genetics reports Q3 EPS (21c), consensus (31c)
- SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023